Dxcover presents first real-world evidence that increased tumor size is associated with higher mortality in brain cancer

Mayo Clinic researchers identify personalized approach to brain cancer monitoring

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most aggressive types of brain cancer.

April 25, 2025

Vol.51 No.16

Drugs & Targets

FDA grants Breakthrough Therapy designation for B7-H3 CAR T-cell therapy for diffuse intrinsic pontine glioma

BrainChild Bio Inc. announced that its investigational B7-H3 targeting autologous CAR T-cell therapy has been granted Breakthrough Therapy designation by FDA for the treatment of diffuse intrinsic pontine glioma, an incurable pediatric brain tumor.

April 25, 2025

Vol.51 No.16

In Brief

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

Michael Chan was appointed chair of Wake Forest University’s Department of Radiation Oncology, which he has led as interim chair since 2023. In his permanent role, he will advance the clinical, research and education missions of the department, while optimizing care delivery and clinical operations.

March 28, 2025

Vol.51 No.12

Clinical Roundup

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Researchers at the University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation.

March 28, 2025

Vol.51 No.12

Clinical Roundup

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children’s Hospital of Pittsburgh developed a new way to profile brain cancers in children.

March 21, 2025

Vol.51 No.11

In Brief

UCLA awarded $1.72M NIH grant to train brain cancer scientists

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from NIH to support the Neuro-Oncology Translational Research Training Program, an initiative designed to train the next generation of brain tumor scientists and physician-scientists.

February 07, 2025

Vol.51 No.05

Dxcover presents first real-world evidence that increased tumor size is associated with higher mortality in brain cancer

YOU MAY BE INTERESTED IN

Mayo Clinic researchers identify personalized approach to brain cancer monitoring

FDA grants Breakthrough Therapy designation for B7-H3 CAR T-cell therapy for diffuse intrinsic pontine glioma

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

UCLA awarded $1.72M NIH grant to train brain cancer scientists

Renew today!

Subscriber content

Never miss an issue!

Login